Pgrs New Life Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 179.67%
- Profit Growth 138.16%
- Ebitda 644.64%
- Net Worth 67.70%
- Total Assets 37.52%
About Pgrs New Life Pharma
Pgrs New Life Pharma Private Limited (PNLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 October 2018 (Six years and four months 20 days old ). Its registered office is in Jhajjar, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Chillar and Praveen Gulia serve as directors at the Company.
Company Details
- Location
Jhajjar, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52603HR2018PTC076235
- Company No.
076235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2018
- Date of AGM
30 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Pgrs New Life Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Chillar  | Director | 03-Oct-2018 | Current |
| Praveen Gulia | Director | 03-Oct-2018 | Current |
Financial Performance of Pgrs New Life Pharma.
Pgrs New Life Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 179.67% increase. The company also saw a substantial improvement in profitability, with a 138.16% increase in profit. The company's net worth Soared by an impressive increase of 67.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pgrs New Life Pharma?
In 2020, Pgrs New Life Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cd Ravik Health Solutions India Private LimitedRavinder Chillar is a mutual person
- Pgrs Health Solution Private Limited
Ravinder Chillar and Praveen Gulia are mutual person
- Stonecure Health Solutions Private Limited
Ravinder Chillar is a mutual person
- Dr Gulia Hospitals (Opc) Private Limited
Praveen Gulia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pgrs New Life Pharma?
Unlock and access historical data on people associated with Pgrs New Life Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pgrs New Life Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pgrs New Life Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.